Many MS genetic risk factors are shared across ancestral backgrounds, but European-focused studies may miss others, per a study.

Guest writer Caitlin Epstein was in the middle of world travels when her MS symptoms worsened, leading to a diagnosis.

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability progression.

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

MS is causing fewer deaths and less disability now than in years past, and the trend will likely continue in the coming years, a study found.

Columnist Desiree Lama finds herself having to argue that a medicine that she has been taking for migraines for years is still needed.

Guest writer Reché Jones says it took her years to be diagnosed with relapsing-remitting MS. Now she plans to "keep moving." ...

When guest writer Antonio Perez turned to social media to learn about MS, he saw a need to help other young people navigate ...

As columnist Ahna Crum marveled at the feats of Olympic medalists, she decided to grab a pair of ice skates and test her own ...

Donald Kushner says living with MS has made him the gravitational center of his family, and the person in the middle in group ...